Chemoembolization in Synchronous Liver Metastases from Nonfunctioning Endocrine Tumor of Pancreas.
- Author:
Keun Ho YANG
1
;
Hong yong KIM
;
Byung Noe BAE
;
Ki Whan KIM
;
Sehwan HAN
;
Hong Joo KIM
;
Young Duck KIM
;
Sung jig IM
Author Information
1. Department of Surgery, Sanggye Paik Hospital, Inje University, Seoul, Korea. ileus@freechal.com
- Publication Type:Case Report
- Keywords:
Pancreatic endocrine tumor;
Nonfunctioning;
Chemoembolization
- MeSH:
Aged;
Carcinoma, Ductal;
Drug Therapy;
Female;
Humans;
Liver*;
Neoplasm Metastasis*;
Pancreas*;
Prognosis
- From:Korean Journal of Hepato-Biliary-Pancreatic Surgery
2002;6(2):195-199
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pancreatic endocrine tumors are rare and represent a heterogeneous group of benign or malignant lesions. In nonfunctioning tumors, lacking the features of an endocrine tumor syndrome, they seldom present until there is advanced local disease. Endocrine tumors of the pancreas, even in case of liver involvement, are generally characterized by a slower evolution and a better prognosis, if compared with ductal carcinoma. This fact gives reason to a radical surgical approach and to the research of any effective adjuvant treatment including hormonal suppression, systemic chemotherapy and hepatic transarterial chemoembolization (TACE). We report a case of synchronous liver metastases from nonfunctioning pancreatic endocrine tumor in 66 year old female patient.
